|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
13 June 2023 |
|
Main ID: |
NCT02413762 |
|
Date of registration:
|
07/04/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Role of Gut Hormones and Hepcidin in Type 2 Diabetes Mellitus
|
|
Scientific title:
|
The Role of Gut Hormones and Hepcidin in Type 2 Diabetes Mellitus |
|
Date of first enrolment:
|
March 2015 |
|
Target sample size:
|
1512 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02413762 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
United Arab Emirates
| | | | | | | |
|
Contacts
|
|
Name:
|
Nader Lessan, MBBS FRCP MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Imperial College London Diabetes Centre |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- all
Exclusion Criteria:
- lack of capacity for informed consent; vulnerable individuals
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Diabetes Mellitus, Type 2
|
|
Intervention(s)
|
|
Other: No intervention
|
|
Primary Outcome(s)
|
|
Macrovascular complication of diabetes mellitus - prevalence and incidence
[Time Frame: 5 years]
|
|
Microvascular complication of diabetes mellitus - prevalence and incidence
[Time Frame: 5 years]
|
|
Secondary Outcome(s)
|
|
Progression to NAFLD or NASH
[Time Frame: 5 years]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|